Global Botanical Drug Competitive Landscape Professional Research Report 2024

Research Summary

A botanical drug, also known as a phytomedicine or a phytopharmaceutical, refers to a drug or medicinal product that is derived from botanical sources, primarily plants or plant extracts. These drugs are developed and formulated using active ingredients obtained from plants, which may include leaves, flowers, stems, roots, or other plant parts. Botanical drugs have been used for centuries in traditional medicine systems, such as Ayurveda, Traditional Chinese Medicine (TCM), and Native American medicine. In recent years, there has been growing interest in the development of botanical drugs within the framework of modern medicine. To be classified as a botanical drug, a product must meet certain criteria and undergo a regulatory approval process. The specific requirements vary depending on the country or regulatory agency involved. In the United States, for example, the U.S. Food and Drug Administration (FDA) has established guidelines for the development, evaluation, and approval of botanical drugs under the category of botanical drug products (BDPs). Botanical drugs can be developed as single-ingredient formulations or as complex mixtures of various plant constituents. They may be used to treat a wide range of conditions, including but not limited to cardiovascular disorders, respiratory diseases, immune disorders, gastrointestinal issues, and skin conditions. It's important to note that while botanical drugs are derived from natural sources, they still undergo rigorous scientific and clinical evaluation to ensure safety, efficacy, and quality. This involves conducting preclinical studies, clinical trials, and adhering to good manufacturing practices to produce standardized and consistent products.

According to DIResearch's in-depth investigation and research, the global Botanical Drug market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Botanical Drug include Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yunnan Baiyao, Tasly Holding Group, Bionorica Se, Weleda, Taiji, Huarun 999, Kwangdong, GW Pharmaceuticals etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Botanical Drug. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Botanical Drug market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Botanical Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Botanical Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Botanical Drug Include:

Buchang Pharmaceuticals

China TCM

Tsumura

Schwabe

Tong Ren Tang

Jumpcan Pharmaceutical

Guangzhou Baiyunshan Pharmaceutical

Yunnan Baiyao

Tasly Holding Group

Bionorica Se

Weleda

Taiji

Huarun 999

Kwangdong

GW Pharmaceuticals

Botanical Drug Product Segment Include:

Prescription Drug

OTC Drug

Botanical Drug Product Application Include:

Cardiovascular

Tumor

Respiratory System

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Botanical Drug Industry PESTEL Analysis

Chapter 3: Global Botanical Drug Industry Porter's Five Forces Analysis

Chapter 4: Global Botanical Drug Major Regional Market Size and Forecast Analysis

Chapter 5: Global Botanical Drug Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Botanical Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Botanical Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Botanical Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Botanical Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Botanical Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Botanical Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Botanical Drug Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Botanical Drug Market Overview

1.1 Product Definition and Statistical Scope

1.2 Botanical Drug Product by Type

1.2.1 Global Botanical Drug Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Prescription Drug

1.2.3 OTC Drug

1.3 Botanical Drug Product by Application

1.3.1 Global Botanical Drug Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Cardiovascular

1.3.3 Tumor

1.3.4 Respiratory System

1.3.5 Others

1.4 Global Botanical Drug Market Revenue Analysis (2019-2030)

1.5 Botanical Drug Market Development Status and Trends

1.5.1 Botanical Drug Industry Development Status Analysis

1.5.2 Botanical Drug Industry Development Trends Analysis

2 Botanical Drug Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Botanical Drug Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Botanical Drug Market Analysis by Regions

4.1 Botanical Drug Overall Market: 2023 VS 2024 VS 2030

4.2 Global Botanical Drug Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Botanical Drug Revenue and Market Share by Region (2019-2024)

4.2.2 Global Botanical Drug Revenue Forecast by Region (2025-2030)

5 Global Botanical Drug Market Size by Type and Application

5.1 Global Botanical Drug Market Size by Type

5.2 Global Botanical Drug Market Size by Application

6 North America

6.1 North America Botanical Drug Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Botanical Drug Market Size by Type

6.4 North America Botanical Drug Market Size by Application

6.5 North America Botanical Drug Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Botanical Drug Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Botanical Drug Market Size by Type

7.4 Europe Botanical Drug Market Size by Application

7.5 Europe Botanical Drug Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Botanical Drug Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Botanical Drug Market Size by Type

8.4 China Botanical Drug Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Botanical Drug Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Botanical Drug Market Size by Type

9.4 APAC (excl. China) Botanical Drug Market Size by Application

9.5 APAC (excl. China) Botanical Drug Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Botanical Drug Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Botanical Drug Market Size by Type

10.4 Latin America Botanical Drug Market Size by Application

10.5 Latin America Botanical Drug Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Botanical Drug Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Botanical Drug Market Size by Type

11.4 Middle East & Africa Botanical Drug Market Size by Application

11.5 Middle East & Africa Botanical Drug Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Botanical Drug Market Revenue by Key Manufacturers (2020-2024)

12.2 Botanical Drug Competitive Landscape Analysis and Market Dynamic

12.2.1 Botanical Drug Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Buchang Pharmaceuticals

13.1.1 Buchang Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Buchang Pharmaceuticals Botanical Drug Product Portfolio

13.1.3 Buchang Pharmaceuticals Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 China TCM

13.2.1 China TCM Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 China TCM Botanical Drug Product Portfolio

13.2.3 China TCM Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Tsumura

13.3.1 Tsumura Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Tsumura Botanical Drug Product Portfolio

13.3.3 Tsumura Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Schwabe

13.4.1 Schwabe Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Schwabe Botanical Drug Product Portfolio

13.4.3 Schwabe Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Tong Ren Tang

13.5.1 Tong Ren Tang Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Tong Ren Tang Botanical Drug Product Portfolio

13.5.3 Tong Ren Tang Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Jumpcan Pharmaceutical

13.6.1 Jumpcan Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Jumpcan Pharmaceutical Botanical Drug Product Portfolio

13.6.3 Jumpcan Pharmaceutical Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Guangzhou Baiyunshan Pharmaceutical

13.7.1 Guangzhou Baiyunshan Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product Portfolio

13.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Yunnan Baiyao

13.8.1 Yunnan Baiyao Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Yunnan Baiyao Botanical Drug Product Portfolio

13.8.3 Yunnan Baiyao Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Tasly Holding Group

13.9.1 Tasly Holding Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Tasly Holding Group Botanical Drug Product Portfolio

13.9.3 Tasly Holding Group Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Bionorica Se

13.10.1 Bionorica Se Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Bionorica Se Botanical Drug Product Portfolio

13.10.3 Bionorica Se Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Weleda

13.11.1 Weleda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Weleda Botanical Drug Product Portfolio

13.11.3 Weleda Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 Taiji

13.12.1 Taiji Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Taiji Botanical Drug Product Portfolio

13.12.3 Taiji Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 Huarun 999

13.13.1 Huarun 999 Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Huarun 999 Botanical Drug Product Portfolio

13.13.3 Huarun 999 Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 Kwangdong

13.14.1 Kwangdong Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 Kwangdong Botanical Drug Product Portfolio

13.14.3 Kwangdong Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.15 GW Pharmaceuticals

13.15.1 GW Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 GW Pharmaceuticals Botanical Drug Product Portfolio

13.15.3 GW Pharmaceuticals Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Botanical Drug Industry Chain Analysis

14.2 Botanical Drug Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Botanical Drug Typical Downstream Customers

14.4 Botanical Drug Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support